Yonsei Med J.  2015 Jan;56(1):271-276. 10.3349/ymj.2015.56.1.271.

Reliability and Validity of the Upper Limb Physician's Rating Scale in Children with Cerebral Palsy

Affiliations
  • 1Department of Rehabilitation Medicine, Severance Hospital, Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Korea. werch@yuhs.ac

Abstract

PURPOSE
The Upper Limb Physician's Rating Scale (ULPRS) is a tool that assesses movement quality of the upper limbs. It is used as an outcome measure after botulinum toxin type A injection in children with cerebral palsy (CP). This study aimed to investigate the reliability and validity of the ULPRS in children with spastic CP.
MATERIALS AND METHODS
Thirty children with spastic CP (M:F=17:13) aged 5 to 13 years old were recruited. The ULPRS was scored based on recorded videotapes by four physicians on two separate occasions. The Melbourne Assessment of Unilateral Upper Limb Function (MUUL) was scored by an occupational therapist. Intraclass correlation coefficients (ICCs), 95% confidence intervals and weighted kappa statistics were calculated for the scores of ULPRS to obtain interrater and intrarater reliability. The relationship between ULPRS and MUUL was assessed using Pearson correlation coefficients.
RESULTS
The ICCs for the total ULPRS scores were 0.94 between raters and 0.99 to 1.00 within raters. The weighted kappa statistics for subitem scores for the ULPRS ranged from 0.67 to 1.00 within raters and from 0.46 to 0.86 between raters. The relationship between ULPRS and MUUL was strong (Pearson correlation coefficient=0.751; p<0.05).
CONCLUSION
The results demonstrated the high reliability of the total ULPRS score within and between raters. A significant concurrent validity between ULPRS and MUUL also supports the clinical utility of the ULPRS as an outcome measure of spastic upper limb in children with CP.

Keyword

Upper extremity; botulinum toxin type A injection; outcome measure; Melbourne assessment; unilateral upper limb function

MeSH Terms

Adolescent
Arm/*physiopathology
Cerebral Palsy/*physiopathology
Child
Child, Preschool
Female
Humans
Male
*Physicians
Reproducibility of Results

Figure

  • Fig. 1 Repeat score differences for each rater. Mean: repeat score mean; difference: repeat-score difference; dotted line: median of repeat-score difference; middle solid line: mean of repeat-score difference; top and bottom solid line: 95% limits of agreement for the repeat-score difference.


Reference

1. Mutch L, Alberman E, Hagberg B, Kodama K, Perat MV. Cerebral palsy epidemiology: where are we now and where are we going? Dev Med Child Neurol. 1992; 34:547–551.
Article
2. Graham HK, Aoki KR, Autti-Rämö I, Boyd RN, Delgado MR, Gaebler-Spira DJ, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture. 2000; 11:67–79.
Article
3. Arner M, Eliasson AC, Nicklasson S, Sommerstein K, Hägglund G. Hand function in cerebral palsy. Report of 367 children in a population-based longitudinal health care program. J Hand Surg Am. 2008; 33:1337–1347.
Article
4. Gschwind C, Tonkin M. Surgery for cerebral palsy: Part 1. Classification and operative procedures for pronation deformity. J Hand Surg Br. 1992; 17:391–395.
Article
5. House JH, Gwathmey FW, Fidler MO. A dynamic approach to the thumb-in palm deformity in cerebral palsy. J Bone Joint Surg Am. 1981; 63:216–225.
Article
6. Tonkin M, Gschwind C. Surgery for cerebral palsy: Part 2. Flexion deformity of the wrist and fingers. J Hand Surg Br. 1992; 17:396–400.
Article
7. Zancolli EA, Zancolli ER Jr. Surgical management of the hemiplegic spastic hand in cerebral palsy. Surg Clin North Am. 1981; 61:395–406.
Article
8. Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity. Am J Phys Med Rehabil. 2003; 82:284–289.
Article
9. Koman LA, Mooney JF 3rd, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop. 1994; 14:299–303.
Article
10. Sätilä H, Kotamäki A, Koivikko M, Autti-Rämö I. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases. Pediatr Rehabil. 2006; 9:247–258.
Article
11. Cusick A, Vasquez M, Knowles L, Wallen M. Effect of rater training on reliability of Melbourne Assessment of Unilateral Upper Limb Function scores. Dev Med Child Neurol. 2005; 47:39–45.
Article
12. Bourke-Taylor H. Melbourne Assessment of Unilateral Upper Limb Function: construct validity and correlation with the Pediatric Evaluation of Disability Inventory. Dev Med Child Neurol. 2003; 45:92–96.
Article
13. Gilmore R, Sakzewski L, Boyd R. Upper limb activity measures for 5- to 16-year-old children with congenital hemiplegia: a systematic review. Dev Med Child Neurol. 2010; 52:14–21.
Article
14. Eliasson AC, Krumlinde-Sundholm L, Rösblad B, Beckung E, Arner M, Ohrvall AM, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol. 2006; 48:549–554.
Article
15. Rosenbaum PL, Palisano RJ, Bartlett DJ, Galuppi BE, Russell DJ. Development of the Gross Motor Function Classification System for cerebral palsy. Dev Med Child Neurol. 2008; 50:249–253.
Article
16. Laschinger HK. Intraclass correlations as estimates of interrater reliability in nursing research. West J Nurs Res. 1992; 14:246–251.
Article
17. Mellis C, Peat JK, Williams K, Xuan W. Health science research: a handbook of quantitative methods. Crows Nest, New South Wales: Allen & Unwin;2001.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986; 1:307–310.
Article
19. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care. 1992; 30:917–925.
Article
20. Morris C, Kurinczuk JJ, Fitzpatrick R, Rosenbaum PL. Reliability of the manual ability classification system for children with cerebral palsy. Dev Med Child Neurol. 2006; 48:950–953.
Article
21. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33:159–174.
Article
22. Thorley M, Lannin N, Cusick A, Novak I, Boyd R. Reliability of the quality of upper extremity skills test for children with cerebral palsy aged 2 to 12 years. Phys Occup Ther Pediatr. 2012; 32:4–21.
Article
23. Krumlinde-Sundholm L, Holmefur M, Kottorp A, Eliasson AC. The Assisting Hand Assessment: current evidence of validity, reliability, and responsiveness to change. Dev Med Child Neurol. 2007; 49:259–264.
Article
24. Davids JR, Sabesan VJ, Ortmann F, Wagner LV, Peace LC, Gidewall MA, et al. Surgical management of thumb deformity in children with hemiplegic-type cerebral palsy. J Pediatr Orthop. 2009; 29:504–510.
Article
25. Sorsdahl AB, Moe-Nilssen R, Strand LI. Observer reliability of the Gross Motor Performance Measure and the Quality of Upper Extremity Skills Test, based on video recordings. Dev Med Child Neurol. 2008; 50:146–151.
Article
26. Randall M, Carlin JB, Chondros P, Reddihough D. Reliability of the Melbourne assessment of unilateral upper limb function. Dev Med Child Neurol. 2001; 43:761–767.
Article
27. Spirtos M, O'Mahony P, Malone J. Interrater reliability of the Melbourne Assessment of Unilateral Upper Limb Function for children with hemiplegic cerebral palsy. Am J Occup Ther. 2011; 65:378–383.
Article
28. Klingels K, De Cock P, Desloovere K, Huenaerts C, Molenaers G, Van Nuland I, et al. Comparison of the Melbourne Assessment of Unilateral Upper Limb Function and the Quality of Upper Extremity Skills Test in hemiplegic CP. Dev Med Child Neurol. 2008; 50:904–909.
Article
Full Text Links
  • YMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr